Detalles de la búsqueda
1.
A Pancreatic Cancer Multidisciplinary Clinic Eliminates Socioeconomic Disparities in Treatment and Improves Survival.
Ann Surg Oncol
; 28(5): 2438-2446, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33523364
2.
A phase 2 trial of regorafenib as a single agent in patients with chemotherapy-refractory, advanced, and metastatic biliary tract adenocarcinoma.
Cancer
; 125(6): 902-909, 2019 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30561756
3.
Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma.
Cancer
; 124(17): 3520-3527, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30067863
4.
Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit.
Clin Cancer Res
; 29(4): 723-730, 2023 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36595540
5.
Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504.
Int J Radiat Oncol Biol Phys
; 115(4): 847-860, 2023 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36228746
6.
A Multicenter Randomized Phase II Study of Single Agent Efficacy and Optimal Combination Sequence of Everolimus and Pasireotide LAR in Advanced Thyroid Cancer.
Cancers (Basel)
; 14(11)2022 May 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35681620
7.
Definitive local therapy to head and neck squamous cell carcinoma with distant metastasis.
Laryngoscope Investig Otolaryngol
; 7(3): 757-765, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35734044
8.
Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis.
Clin Epigenetics
; 14(1): 3, 2022 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34991708
9.
A phase â ¡ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patients.
World J Otorhinolaryngol Head Neck Surg
; 8(4): 345-354, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36474663
10.
Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer.
Clin Cancer Res
; 28(7): 1335-1344, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35091445
11.
Long-Term Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy for Recurrent, Previously-Irradiated Head and Neck Cancer.
Front Oncol
; 10: 83, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32117738
12.
Dose-response model for severe late laryngeal toxicity after stereotactic body radiation therapy for previously-irradiated head and neck cancer.
J Radiosurg SBRT
; 7(2): 89-94, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33282462
13.
Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors.
Clin Cancer Res
; 26(20): 5358-5367, 2020 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32816951
14.
Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer.
Cancers (Basel)
; 12(6)2020 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32545260
15.
Transition to a virtual multidisciplinary tumor board during the COVID-19 pandemic: University of Pittsburgh experience.
Head Neck
; 42(6): 1310-1316, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32329958
16.
Dose-response modeling the risk of carotid bleeding events after stereotactic body radiation therapy for previously irradiated head and neck cancer.
J Radiosurg SBRT
; 6(2): 83-89, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31641545
17.
Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT.
Oncoimmunology
; 8(7): 1593805, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31143513
18.
Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer.
J Clin Oncol
; 37(34): 3266-3274, 2019 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31618129
19.
Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy.
Int J Radiat Oncol Biol Phys
; 101(1): 195-200, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29398127
20.
Concurrent Chemoradiotherapy in the Adjuvant Treatment of High-risk Primary Salivary Gland Malignancies.
Am J Clin Oncol
; 41(9): 888-893, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28394767